Daiwa Securities Group

Daiwa Securities Group’s Cullinan Oncology CGEM Stock Holding History

Daiwa Securities Group’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-218	Closed	-$2K	–	1236
2025 Q4	$2K	Hold	218	–	–	﹤0.01%	1297
2025 Q3	$1K	Hold	218	–	–	﹤0.01%	1304
2025 Q2	$2K	Hold	218	–	–	﹤0.01%	1207
2025 Q1	$2K	Hold	218	–	–	﹤0.01%	1177
2024 Q4	$3K	Hold	218	–	–	﹤0.01%	1188
2024 Q3	$4K	Hold	218	–	–	﹤0.01%	1178
2024 Q2	$4K	Buy	218 +91	+72%	+$1.94K	﹤0.01%	1208
2024 Q1	$2K	Hold	127	–	–	﹤0.01%	1262
2023 Q4	$1K	Hold	127	–	–	﹤0.01%	1291
2023 Q3	$1K	Hold	127	–	–	﹤0.01%	1241
2023 Q2	$1K	Hold	127	–	–	﹤0.01%	1262
2023 Q1	$1K	Hold	127	–	–	﹤0.01%	1244
2022 Q4	$1K	Hold	127	–	–	﹤0.01%	1262
2022 Q3	$2K	Hold	127	–	–	﹤0.01%	1218
2022 Q2	$2K	Hold	127	–	–	﹤0.01%	1227
2022 Q1	$1K	Hold	127	–	–	﹤0.01%	1297
2021 Q4	$2K	Buy	+127	New	+$2.53K	﹤0.01%	1276

Other funds holding CGEM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return